EMR at a glance
Emerson Electric (EMR, SEC CIK 32604) filed its latest 10-K annual report on November 9, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on November 13, 2026 and Form 4 insider filings as recently as November 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended September 30, 2026 (FY2026), Emerson Electric (EMR) reported revenue of $19.0 billion (up 5.4% from FY2025) and net income of $2.7 billion. Diluted EPS was $4.79.
- As of September 30, 2026, 64 institutional investment managers tracked by SignalX reported holding Emerson Electric (EMR) shares worth $34.3 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Train Michael H. on November 12, 2026 of 17,427 shares at $168.54 per share.
- In the last 90 days, EMR insiders reported 0 open-market purchases ($0) and 1 open-market sale ($2.9M) on Form 4, a net sale of $2.9M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2026
- $19.0B
- +5.4% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$2.9M
- 13F holders
- 64 funds
- $34.3B · −3 vs prior quarter
- Latest 8-K
- Nov 13, 2026
- Item 8.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Sep 30, 2026
Business Overview
- Core model: Global automation portfolio serving process, hybrid and discrete manufacturers through software, systems, intelligent devices and safety solutions
- New fiscal 2026 structure: Five segments across Software & Systems, Intelligent Devices and Safety & Productivity
- AspenTech fully integrated after $7.2 billion acquisition, expanding Control Systems & Software with asset optimization software
- Backlog reached $9.6 billion, up from $8.6 billion, with 70% expected as revenue within 12 months
- Employee engagement rose to 80% from 79%, with 93% survey participation and approximately 70,000 employees
Risk Factors
- U.S. Supreme Court February 2026 ruling limiting IEEPA tariff authority, followed by retaliatory measures and rapidly changing trade policies
- Emerging-market sales over one-third of total sales, exposing global facilities and suppliers to Russia-Ukraine and Middle East conflicts
- Majority of manufacturing facilities outside the United States, vulnerable to disruptions from war, political unrest and natural disasters
- Artificial intelligence competition, including faster-moving rivals developing superior products and services
- Capital-markets access dependence for acquisitions, investment and refinancing maturing debt obligations
Management Discussion & Analysis
- Revenue $19.0B, up 5% YoY, with underlying sales up 4%
- Gross margin 53.4% vs 52.8%; continuing-operations earnings margin 14.2% vs 12.6%
- Best segment: Intelligent Devices, sales $10.5B, earnings $2,643, margin 25.2%; worst: Safety & Productivity, margin 19.2%
- Operating cash flow $3,978M, free cash flow $3,535M; buybacks $1,000M, dividends $1,244M, capex $443M
- Fiscal 2027 outlook: sales up approximately 5%, adjusted EPS approximately $7.25; Middle East conflict containment assumption
AI summary of the EMR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- €750 million senior unsecured debt issuance completed, increasing Emerson’s financing capacity
- 4.000% fixed annual coupon, with interest payments beginning November 13, 2027
Item 8.01: Other Events
- €750 million senior unsecured notes issued at 4.000% interest, maturing November 13, 2032
- Net proceeds approximately €744.5 million, or $830.4 million, primarily for commercial paper repayment
Item 2.02: Results of Operations and Financial Condition
- Emerson reported fourth-quarter and full-year fiscal 2026 results on November 4, 2026
- Underlying orders measure trailing three-month average growth versus prior year, excluding currency and significant portfolio changes
Item EX-99.1: Item EX-99.1
- Q4 sales $5,201M, up 7%, with underlying orders up 14%, signaling strong demand and backlog support entering FY27
- Profitability strengthened: GAAP EPS $1.33, up 24%, while pretax margin expanded to 19.2% from 15.6%
AI summaries of EMR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for EMR
Don't miss the next EMR filing
- Alerts as it files. A push when EMR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut EMR, by share count.
- Ask anything. An AI agent that reads every EMR filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Train Michael H. | Sell | Nov 12, 2026 | 17,427 | $168.54 |
| Train Michael H. | F | Nov 6, 2026 | 1,431 | $163.06 |
| Mitra Sabyaschi | F | Nov 6, 2026 | 410 | $163.06 |
| Krishnan Ram R. | F | Nov 6, 2026 | 4,293 | $163.06 |
| Flavin Lisa | F | Nov 6, 2026 | 1,002 | $163.06 |
| Karsanbhai Surendralal Lanca | F | Nov 6, 2026 | 10,016 | $163.06 |
| Ramnath Vidya | F | Nov 6, 2026 | 293 | $163.06 |
| Piazza Nicholas J. | F | Nov 6, 2026 | 859 | $163.06 |
Financial SummaryXBRL
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $18.0B | $19.0B |
| Gross Profit | $8.9B | $9.5B | $10.1B |
| Net Income | $2.0B | $2.3B | $2.7B |
| Gross Margin | - | 52.8% | 53.4% |
| Net Margin | - | 12.7% | 14.2% |
| Balance Sheet | |||
| Total Assets | - | $42.0B | $41.8B |
| Equity | - | $20.3B | $20.7B |
| ROE | - | 11.3% | 13.0% |
| Per Share | |||
| EPS | - | $4.04 | $4.79 |
| Cash Flow | |||
| Operating CF | $3.3B | $3.1B | $4.0B |
| CapEx | $419.0M | $431.0M | $443.0M |
Source: XBRL data in Emerson Electric (EMR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate EMR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 64 | $34.27B |
| Q2 2026 | 67 | $32.79B |
| Q1 2026 | 65 | $29.94B |
| Q4 2025 | 60 | $30.62B |
| Q3 2025 | 62 | $33.04B |
| Q2 2025 | 61 | $29.66B |
| Q1 2025 | 59 | $18.93B |
| Q4 2024 | 55 | $16.80B |
- AQR Capital Management+797.1K (+382%)
- Ameriprise Financial+598.4K (+11%)
- D.E. Shaw & Co+358.2K (+49%)
- Morgan Stanley+279.1K (+2%)
- T. Rowe Price Group+197.7K (+2%)
- JPMorgan Chase & Co−4.02M (-37%)
- Invesco Ltd−1.26M (-18%)
- Bank of America Corp−492.5K (-3%)
- Wells Fargo & Co−383.6K (-4%)
- Goldman Sachs Group−185.1K (-4%)
- AlTi Global, Inc.+2.2K
- FMR LLC (Fidelity)−4.04M
- Equitable Holdings Inc−59.9K
- Northwest Bancshares, Inc.−9.1K
- Ally Financial Inc−8.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 493 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
EMR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 16, 2026 | - | - | - |
| 8-K | Nov 13, 2026 | - | Analysis | - |
| 8-K | Nov 12, 2026 | - | Analysis | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 10-K | Nov 9, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 6, 2026 | - | - | - |
| 4 | Nov 4, 2026 | - | - | - |
Related Industrials companies
- GE · GE AerospaceElectronic & Other Electrical Equipment (No Computer Equip)
- GEV · GE VernovaElectronic & Other Electrical Equipment (No Computer Equip)
- OTIS · Otis WorldwideElectronic & Other Electrical Equipment (No Computer Equip)
- MMM · 3MSurgical & Medical Instruments & Apparatus
- AOS · A. O. SmithHousehold Appliances
- AIR · AAR CORPAircraft & Parts
- ABM · ABM INDUSTRIES INC /DE/Services-To Dwellings & Other Buildings
- ACU · ACME UNITED CORPCutlery, Handtools & General Hardware
EMR SEC filings: frequently asked questions
Are EMR insiders buying or selling?
In the last 90 days, Emerson Electric (EMR) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $2.9 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold EMR stock?
As of September 30, 2026, the largest Emerson Electric (EMR) holders among the 13F filers tracked by SignalX were BlackRock ($6.7 billion), Vanguard Capital Management LLC ($5.7 billion), State Street Corp ($4.3 billion), Bank of America Corp ($2.8 billion), Vanguard Portfolio Management LLC ($2.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.
What was EMR's revenue in fiscal year 2026?
For the fiscal year ended September 30, 2026 (FY2026), Emerson Electric (EMR) reported revenue of $19.0 billion (up 5.4% from FY2025) and net income of $2.7 billion. Diluted EPS was $4.79. The figures come from the XBRL data in the 10-K.
What are the main risks in EMR's latest 10-K?
In the 10-K filed November 9, 2026, Emerson Electric (EMR) flagged: U.S. Supreme Court February 2026 ruling limiting IEEPA tariff authority, followed by retaliatory measures and rapidly changing trade policies. Emerging-market sales over one-third of total sales, exposing global facilities and suppliers to Russia-Ukraine and Middle East conflicts. (AI summary of the Risk Factors section.)
What did EMR report in its latest 8-K?
Emerson Electric (EMR) filed an 8-K on November 13, 2026 reporting Item 8.01 (Other Events). €750 million senior unsecured debt issuance completed, increasing Emerson’s financing capacity.
What are the latest EMR SEC filings?
Emerson Electric (EMR) filed its latest 10-K annual report on November 9, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on November 13, 2026 and a Form 4 insider filing on November 16, 2026.
What is EMR's SEC CIK number?
Emerson Electric (EMR)'s SEC Central Index Key (CIK) is 32604. EDGAR lists every EMR filing under that number.
Ask anything about EMR
The research agent reads EMR's filings, financials, insider trades and 13F holders, then answers with sources.